Rsvpref3 Antigen/As01e/Pf
Brand name: Arexvy
Rank #30 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$608.6M
Total Cost
1,935,431
Total Claims
$608.6M
Total Cost
10,631
Prescribers
$314
Cost per Claim
1,933,590
Beneficiaries
1,936,732
30-Day Fills
$57K
Avg Cost/Provider
182
Avg Claims/Provider
Share of Medicare Part D Spending
0.22%
of total Medicare Part D spending
$608.6M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $608.6M total
🔎 Data Overview
Ranked #30 out of 500 drugs tracked by total cost. Rsvpref3 Antigen/As01e/Pf represents a significant portion of Medicare drug spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Rsvpref3 Antigen/As01e/Pf
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Cedric Davis | Family Practice | Lauderdale Lakes, FL | 177,334 | $56.5M |
| 2 | John Bogdasarian | Otolaryngology | Fitchburg, MA | 125,559 | $39.5M |
| 3 | Shaun Gill | Hospitalist | Doylestown, PA | 97,491 | $30.2M |
| 4 | Jai Wadhwani | Cardiology | Williamsville, NY | 94,603 | $29.3M |
| 5 | Eldridge Burns | Family Practice | El Campo, TX | 91,375 | $28.9M |
| 6 | Ruth Mays | Family Practice | Highland Park, MI | 87,363 | $26.8M |
| 7 | Winnie Mann | Specialist | Redmond, WA | 85,393 | $26.4M |
| 8 | Richard Clark | Family Practice | Marietta, OH | 73,335 | $23.2M |
| 9 | Krishdeep Khosla | Internal Medicine | Oakbrook Terrace, IL | 56,017 | $18.0M |
| 10 | Martin Duclos | Internal Medicine | Conway, SC | 54,169 | $17.3M |
| 11 | Janelle Duah | Internal Medicine | Bridgeport, CT | 40,350 | $12.9M |
| 12 | Tejal Joseph | Family Practice | Fenton, MI | 25,704 | $7.8M |
| 13 | Jason Mcelyea | Emergency Medicine | Mcalester, OK | 23,831 | $7.6M |
| 14 | Cathy Hurley | Internal Medicine | Kerrville, TX | 23,933 | $7.5M |
| 15 | Jeremy Cushman | Emergency Medicine | Rochester, NY | 22,498 | $6.8M |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 27 | Linaclotide (Linzess) | $639.4M | 823,023 |
| 28 | Insulin Lispro (Humalog Kwikpen U-100) | $623.9M | 854,813 |
| 29 | Dupilumab (Dupixent Pen) | $609.1M | 156,267 |
| 30 | Rsvpref3 Antigen/As01e/Pf (Arexvy) | $608.6M | 1,935,431 |
| 31 | Pomalidomide (Pomalyst) | $589.0M | 27,253 |
| 32 | Lipase/Protease/Amylase (Zenpep) | $577.7M | 321,809 |
| 33 | Insulin Degludec (Tresiba Flextouch U-100) | $567.8M | 597,178 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology